Definition:Mortality study
📈 Mortality study is a systematic actuarial investigation that analyzes death rates within a defined population to develop, validate, or update the mortality assumptions used in pricing, reserving, and managing life insurance, annuity, and pension products. These studies form the empirical backbone of the life insurance industry, translating raw experience data into the statistical models that determine how much premium to charge, how large reserves must be, and how long policyholders or annuitants are expected to live. Whether conducted by individual carriers, reinsurers, industry bodies, or regulatory organizations, mortality studies are among the most consequential analytical exercises in the insurance sector.
⚙️ Conducting a mortality study involves collecting exposure and claims data over a defined observation period, typically spanning multiple years, and analyzing actual deaths relative to expected deaths under a reference mortality table. The study measures actual-to-expected (A/E) ratios across various dimensions — age, gender, underwriting class, product type, policy duration, smoking status, and other risk factors — to identify where experience deviates from assumptions. Large insurers and reinsurers conduct proprietary studies using their own book data, while organizations such as the Society of Actuaries in the United States, the Continuous Mortality Investigation in the United Kingdom, and analogous bodies in Japan, Germany, and other markets publish industry-wide tables derived from pooled data. These published tables — such as the SOA's Valuation Basic Tables or the CMI's mortality projections — serve as benchmarks that regulators often mandate or reference for statutory reserving and solvency calculations.
💡 The insights generated by mortality studies ripple through virtually every aspect of life insurance operations. When a study reveals that mortality is improving faster than anticipated — a trend known as longevity improvement — annuity writers face increased liabilities, while life insurers may benefit from lower-than-expected claims. Conversely, events like the COVID-19 pandemic triggered ad hoc mortality studies across global markets to quantify excess deaths and recalibrate near-term assumptions. Regulatory frameworks reflect the centrality of these studies: under IFRS 17, insurers must use current best-estimate mortality assumptions that are regularly updated based on experience analysis, while Solvency II requires explicit stress testing of mortality and longevity assumptions in the solvency capital requirement calculation. As data availability expands — through electronic health records, wearable devices, and enhanced predictive analytics — the granularity and frequency of mortality studies continue to increase, enabling more accurate and responsive pricing across the life insurance industry.
Related concepts: